Nanosensors target enzymes to monitor and study cancer
By analyzing enzyme activity at the organism, tissue, and cellular scales, new sensors could provide new tools to clinicians and cancer researchers.
By analyzing enzyme activity at the organism, tissue, and cellular scales, new sensors could provide new tools to clinicians and cancer researchers.
At an exhibition marking two decades since a transformative gift from the Picower Foundation, current and alumni members described research at the forefront of neuroscience and beyond.
“AI for endometriosis? If only there were data!”
Test that measures a person’s antibodies requires a drop of blood and takes just 10 minutes to show results.
A machine-learning method finds patterns of health decline in ALS, informing future clinical trial designs and mechanism discovery. The technique also extends to Alzheimer’s and Parkinson’s.
By continuously monitoring a patient’s gait speed, the system can assess the condition’s severity between visits to the doctor’s office.
A new model that maps developmental pathways to tumor cells may unlock the identity of cancers of unknown primary.
Developed by the Singapore-MIT Alliance for Research and Technology, the assay can provide new details about the type of SARS-CoV-2 circulating in a community.
The paper test measures the level of neutralizing antibodies in a blood sample and could help people decide what protections they should take against infection.
With particles that release their payloads at different times, one injection could provide multiple vaccine doses.
The grants total over $1 million in support of research that addresses issues in the water and food sectors.
MIT and Mass General Brigham researchers and physicians connect in person to bring AI into mainstream health care.
Professor Polina Anikeeva’s innovation in the treatment of neurological disorders highlights the interdisciplinary nature of her field.
Competitive seed grants launch yearlong investigations of novel hypotheses about potential causes, biomarkers, treatments of Alzheimer’s and ALS.
Postdoc Digbijay Mahat became a cancer researcher to improve health care in Nepal, but the Covid-19 pandemic exposed additional resource disparities.